Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women (HOP-IN)

This study has been completed.
Sponsor:
Collaborator:
Merck
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT01289873
First received: February 2, 2011
Last updated: February 7, 2013
Last verified: February 2013

February 2, 2011
February 7, 2013
May 2011
September 2012   (final data collection date for primary outcome measure)
Prevalence of oral HPV [ Time Frame: at enrollment ] [ Designated as safety issue: No ]
any oral HPV at enrollment
Not Provided
Complete list of historical versions of study NCT01289873 on ClinicalTrials.gov Archive Site
Persistence of oral HPV over 1 year of follow-up [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Determine whether HPV remains present at 3-months, 6-months, and 12-months after enrollment
Not Provided
Not Provided
Not Provided
 
Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women
Prevalence, Persistence, and Risk Factors for Oral HPV Infections in College Women

The purpose of this study is to determine how common oral HPV infections are in college women. The investigators also will find out what risk factors are associated with having oral HPV infections. The investigators hypothesize that approximately 3% of women will have oral HPV, and that HPV will be associated with oral sexual behaviors and with smoking behaviors. Finally, for those women with oral HPV- the investigators will determine whether the infections are persistent (still present) at 3-, 6-, and 12-months after the initial diagnosis.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

female college students

Human Papillomavirus
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1035
September 2012
September 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age >=18 years
  • Female
  • Currently enrolled as a college student

Exclusion Criteria:

  • Unable to provide an oral rinse sample
  • Unable to complete survey
  • Unable to provide contact information
  • Already completed study.
Female
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01289873
Merck IISP 37942
No
University of Florida
University of Florida
Merck
Principal Investigator: Robert L Cook, MD, MPH University of Florida
University of Florida
February 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP